BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25959245)

  • 21. Risk factors associated with earlier age of onset in familial pancreatic carcinoma.
    James TA; Sheldon DG; Rajput A; Kuvshinoff BW; Javle MM; Nava HR; Smith JL; Gibbs JF
    Cancer; 2004 Dec; 101(12):2722-6. PubMed ID: 15534880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary pancreatic cancer.
    Lynch HT; Brand RE; Deters CA; Shaw TG; Lynch JF
    Pancreatology; 2001; 1(5):466-71. PubMed ID: 12120226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and pathologic features of familial pancreatic cancer.
    Humphris JL; Johns AL; Simpson SH; Cowley MJ; Pajic M; Chang DK; Nagrial AM; Chin VT; Chantrill LA; Pinese M; Mead RS; Gill AJ; Samra JS; Kench JG; Musgrove EA; Tucker KM; Spigelman AD; Waddell N; Grimmond SM; Biankin AV;
    Cancer; 2014 Dec; 120(23):3669-75. PubMed ID: 25313458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated cancer mortality in the relatives of patients with pancreatic cancer.
    Wang L; Brune KA; Visvanathan K; Laheru D; Herman J; Wolfgang C; Schulick R; Cameron JL; Goggins M; Hruban RH; Klein AP
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2829-34. PubMed ID: 19843679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial Pancreatic Cancer and the Future of Directed Screening.
    Welinsky S; Lucas AL
    Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.
    Canto MI; Harinck F; Hruban RH; Offerhaus GJ; Poley JW; Kamel I; Nio Y; Schulick RS; Bassi C; Kluijt I; Levy MJ; Chak A; Fockens P; Goggins M; Bruno M;
    Gut; 2013 Mar; 62(3):339-47. PubMed ID: 23135763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer.
    Poley JW; Kluijt I; Gouma DJ; Harinck F; Wagner A; Aalfs C; van Eijck CH; Cats A; Kuipers EJ; Nio Y; Fockens P; Bruno MJ
    Am J Gastroenterol; 2009 Sep; 104(9):2175-81. PubMed ID: 19491823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications.
    Singh M; Maitra A
    Pancreatology; 2007; 7(1):9-19. PubMed ID: 17449961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection of pancreatic cancer: why, who, and how to screen.
    Klapman J; Malafa MP
    Cancer Control; 2008 Oct; 15(4):280-7. PubMed ID: 18813195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial pancreatic cancer.
    Hruban RH; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Falatko F; Yeo CJ; Kern SE
    Ann Oncol; 1999; 10 Suppl 4():69-73. PubMed ID: 10436789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.
    Brune K; Abe T; Canto M; O'Malley L; Klein AP; Maitra A; Volkan Adsay N; Fishman EK; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Am J Surg Pathol; 2006 Sep; 30(9):1067-76. PubMed ID: 16931950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended radical pancreatectomy for carcinoma of the head of the pancreas.
    Nagakawa T; Konishi I; Ueno K; Ohta T; Kayahara M; Miyazaki I
    Hepatogastroenterology; 1998; 45(21):849-54. PubMed ID: 9684146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenocarcinoma of the pancreas: Does prognosis depend on mode of lymph node invasion?
    Buc E; Couvelard A; Kwiatkowski F; Dokmak S; Ruszniewski P; Hammel P; Belghiti J; Sauvanet A
    Eur J Surg Oncol; 2014 Nov; 40(11):1578-85. PubMed ID: 24923739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals.
    Matsubayashi H
    J Gastroenterol; 2011 Nov; 46(11):1249-59. PubMed ID: 21847571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients.
    Shi C; Klein AP; Goggins M; Maitra A; Canto M; Ali S; Schulick R; Palmisano E; Hruban RH
    Clin Cancer Res; 2009 Dec; 15(24):7737-7743. PubMed ID: 19996207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management strategies for patients with hereditary pancreatic cancer.
    Brentnall TA
    Curr Treat Options Oncol; 2005 Sep; 6(5):437-45. PubMed ID: 16107246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management of hereditary pancreatic cancer.
    Davis B; Lowy AM
    Med Clin North Am; 2000 May; 84(3):749-59. PubMed ID: 10872430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic neck cancer has specific and oncologic characteristics regarding portal vein invasion and lymph node metastasis.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yamaue H
    Surgery; 2016 Feb; 159(2):426-40. PubMed ID: 26253244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Individuals at high-risk for pancreatic cancer development: management options and the role of surgery.
    Sakorafas GH; Tsiotos GG; Korkolis D; Smyrniotis V
    Surg Oncol; 2012 Jun; 21(2):e49-58. PubMed ID: 22244849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.